Lupin gets CDSCO nod for 2nd generation antihistanine medicine
The Central Drugs Standard Control Organisation (CDSCO) has given its approval to Mumbai-based multinational pharmaceutical company Lupin Limited for Bepotastine […]
Dr. Reddy’s gets USFDA approval for anti-cancer injection
Dr. Reddy’s has received an approval from US Food and Drug Administration (USFDA) for the launch of Doxorubicin Hydrochloride Liposome […]
Dr Reddys Lab, Gland Pharma to market generic injectables globally
Dr Reddys Laboratories and US-based Gland Pharma have collaborated to market and distribute a diverse portfolio of eight injectable Abbreviated […]
IMS Health acquires baring PE funded PharmARC
US based Healthcare analytics provider – IMS Health Inc. has acquired Baring PE backed PharmARC Analytics Solutions Pvt Ltd. Financial […]
Hospital chemist shops gaining importance
An audit of medicine sales shows that the drugs are fast selling in the hospitals than in chemist shops.
Drugs : Dr Reddy
Drugs Dr Reddy’s announces the launch of Pantoprazole Sodium delayed-released tablets Dr Reddy’s Laboratories has launched Pantoprazole Sodium Delayed-Released tablets(20mg […]
Lupin gets FDA nod for anti-allergic tablets
Drug firm Lupin announced it has been granted final approval by the United states Food and Drug Administration (USFDA) for antihistamine Desloratadine tablets, used for treating allergies.
